AtriCure Appoints Scott Drake to Its Board of Directors

AtriCure (NASDAQ: ATRC ), a medical device company and a leader in the development of technologies and solutions for the treatment of atrial fibrillation, or Afib, and systems for the exclusion of the left atrial appendage, today announced that Scott Drake, Chief Executive Officer of the Spectranetics Corporation, has